Our NephJC STOP-ACEi editorial in Kidney Medicine is live. Great work from Susan Thanabalasingam and Cristina Popa, supported by Nayan, Swap, and Jade.
Read it here.
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.
Our NephJC STOP-ACEi editorial in Kidney Medicine is live. Great work from Susan Thanabalasingam and Cristina Popa, supported by Nayan, Swap, and Jade.
Read it here.
Episode 055: The Filtrate try to figure out STOP ACE with the assistance of Laurie Tomlinson.
If you missed the latest NephJC discussion, at least read the highlights here.
You gotta know when to hold’em and know when to fold’em. Review the #TenTweetNephJC for the STOP ACEi Trial, and always hold onto your ACEi.
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) December 1, 2022
✳️ 10 tweets #NephJC catch-up ✳️ pic.twitter.com/n8dcopDLPT
Does the discontinuation of RAS inhibitors improve eGFR in patients with advanced CKD? NSMC Intern Dana Larsen explains it graphically.